Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8K Buy
44
+1
+2% +$342 0.01% 329
2026
Q1
$15.3K Sell
43
-19
-31% -$6.77K 0.01% 306
2025
Q4
$20.4K Buy
+62
New +$19.7K 0.01% 284

Other funds holding AMGN

PFS Partners's AMGN Position: Q2 2026 in Review

PFS Partners increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $342 and bringing the position to 44 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #329.

PFS Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.4K in Q4 2025. 1,241 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PFS Partners held 44 shares of Amgen worth $15.8K as of Q2 2026.
  • PFS Partners bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.01% of PFS Partners's portfolio in Q2 2026, its #329 holding.
  • PFS Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • PFS Partners's Amgen position peaked at $20.4K in Q4 2025.
  • 1,241 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.